MyCEI Login


ECHO: Harm Reduction and Mental Health


Published Date: 08/24/2022

CE Credit: No CE


In this presentation, Dan Suter speaks to the intersection of harm reduction and mental health care while highlighting the prevalence of comorbid substance use disorders and mental illnesses. Dan outlines specific barriers that people who use drugs face when accessing mental health care. Additionally, he shares a variety of screening tools for mental health diagnoses, including but not limited to the Clinically Useful Anxiety Outcome Scale (CUAOS), the Hospital Anxiety and Depression Scale (HADS), and the Mood Disorder Questionnaire (MDQ). In this discussion, he highlights the strengths and limitations of the various tools in the context of providing care to people who use drugs. Dan also outlines various ways to limit side effects from psychotropic medications.


Daniel Suter,MD

Daniel Suter, MD was born and raised in Pittsburgh, Pennsylvania before attending college at the University of Toronto and working for a period in Montreal. He returned to the University of Pittsburgh for Medical School and completed his Psychiatry Residency at the Icahn School of Medicine at Mount Sinai in NYC. He subsequently completed an Addiction Psychiatry Fellowship through the Mount Sinai Addiction Institute. Currently he is an attending on the inpatient detox/rehab and consultation services at the Addiction Institute, where he is involved in teaching trainees and clinical care. 

Continuing Education Credit Information